SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001013594-20-000498
Filing Date
2020-05-15
Accepted
2020-05-15 11:02:16
Documents
1

Document Format Files

Seq Description Document Type Size
1 bausch13da1-051520.htm SC 13D/A 38567
  Complete submission text file 0001013594-20-000498.txt   40514
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Subject) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-45947 | Film No.: 20882004
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 1133 AVENUE OF THE AMERICAS 33RD FLOOR NEW YORK NY 10036
Business Address 1133 AVENUE OF THE AMERICAS 33RD FLOOR NEW YORK NY 10036 212-956-2221
PAULSON & CO. INC. (Filed by) CIK: 0001035674 (see all company filings)

IRS No.: 133796759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A